tirzepatide biologic Premium Peptide | Dual Agonist Tirzepatide And Semaglutide: Experts Explain

This finding suggests that extending treatment well beyond 12 weeks may allow additional patients to achieve clinically meaningful weight reduction

However, split dosing is not FDA-approved

The gradual escalation gives your body time to adjust and reduces gastrointestinal side effects that are most common during dose changes

[2] [3] Conditions such as hypothyroidism, polycystic ovary syndrome, or Cushing's syndrome can impact weight loss response and may require additional management

When you eat, tirzepatide tells your stomach to hold onto food longer

This decision relies on health outcomes, drug administration, and your treatment goals